Retatrutide is a triple agonist research compound investigated in laboratory studies related to GLP-1, GIP, and glucagon receptor activity. Supplied as a 10mg lyophilized powder in a sterile single-use vial for in-vitro research applications.
Specifications:
– Quantity: 10mg per vial
– Form: Lyophilized powder
– Purity: ≥98% (verified by HPLC)
– Storage: Store lyophilized at -20°C protected from light. After reconstitution, refrigerate at 2-8°C and use within 30 days.
For research and educational use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease. Certificate of Analysis available upon request.
